Published: 11 August 2014
Author(s): Daniela Concolino, Emilia Degennaro, Rossella Parini, on behalf of the Fabry Delphi working group
Management of Anderson–Fabry disease (AFD) is contentious, particularly regarding enzyme replacement therapy (ERT). We report results of a Delphi consensus panel on AFD management.
